Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

In theory, the path forward is clear: interoperability, data-driven manufacturing, and smarter scheduling powered by AI. Imagine simply inputting what you want to make — dimensions, material — and the ...

IT giant HCL Tech has announced its plan to change its quarterly variable pay policy to fixed salaries for all employees and roll out salary increments from October, following last year's process. “We ...

Automakers face higher costs from US port fees, car carrier Wallenius Wilhelmsen warns Automakers transporting their cars to the U.S. could face $200 to $300 per vehicle in additional costs, the CEO ...